Nchi: Marekani
Lugha: Kiingereza
Chanzo: NLM (National Library of Medicine)
BISOPROLOL FUMARATE (UNII: UR59KN573L) (BISOPROLOL - UNII:Y41JS2NL6U)
Bryant Ranch Prepack
ORAL
PRESCRIPTION DRUG
BISOPROLOL FUMARATE TABLETS, USP are indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents. BISOPROLOL FUMARATE is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree AV block, and marked sinus bradycardia.
BISOPROLOL FUMARATE TABLETS, USP 5 mg tablet is pink, round, uncoated tablet debossed "N455" on one side and scored on other side. NDC: 71335-2178-1: 30 Tablets in a BOTTLE NDC: 71335-2178-2: 100 Tablets in a BOTTLE NDC: 71335-2178-3: 90 Tablets in a BOTTLE NDC: 71335-2178-4: 28 Tablets in a BOTTLE NDC: 71335-2178-5: 120 Tablets in a BOTTLE Store at 20° to 25°C (68° to 77°F). [see USP Controlled Room Temperature]. Protect from moisture. Dispense in tight, light-resistant containers. Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 9150
Abbreviated New Drug Application
BISOPROLOL FUMARATE- BISOPROLOL FUMARATE TABLET BRYANT RANCH PREPACK ---------- BISOPROLOL FUMARATE TABLETS, USP RX ONLY DESCRIPTION BISOPROLOL FUMARATE, USP is a synthetic, beta -selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is (±)-1-[4-[[2- (1- Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol (E)-2- butenedioate (2:1) (salt). It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. The S(-) enantiomer is responsible for most of the beta- blocking activity. Its molecular formula is (C H NO ) • C H O and its structure is: Bisoprolol fumarate has a molecular weight of 766.96. It is a white crystalline powder which is approximately equally hydrophilic and lipophilic, and is readily soluble in water, methanol, ethanol, and chloroform. BISOPROLOL FUMARATE TABLETS, USP are available as 5 and 10 mg tablets for oral administration. Inactive ingredients include: microcrystalline cellulose, pregelatinized starch, dicalcium phosphate, colloidal silicon dioxide, magnesium stearate, iron oxide red and ferrosoferric oxide. 1 18 31 4 2 4 4 4 FDA approved dissolution test specifications differ from USP. CLINICAL PHARMACOLOGY BISOPROLOL FUMARATE is a beta -selective (cardioselective) adrenoceptor blocking agent without significant membrane stabilizing activity or intrinsic sympathomimetic activity in its therapeutic dosage range. Cardioselectivity is not absolute, however, and at higher doses (≥ 20 mg) bisoprolol fumarate also inhibits beta -adrenoceptors, chiefly located in the bronchial and vascular musculature; to retain selectivity it is therefore important to use the lowest effective dose. PHARMACOKINETICS AND METABOLISM The absolute bioavailability after a 10 mg oral dose of bisoprolol fumarate is about 80%. Absorption is not affected by the presence of food. The first pass metabolism of bisoprolol fumarate is about 20%. Binding to serum proteins is approximately 30%. Peak plasma concentrations occur within Soma hati kamili